Biosante Pharmaceuticals Inc (NASDAQ:BPAX)

CAPS Rating: 2 out of 5

A biopharmaceutical company that licenses and develops hormone therapy products to treat men and women.

Recs

0
Player Avatar benyboy (< 20) Submitted: 7/9/2012 10:42:11 AM : Outperform Start Price: $1.65 BPAX Score: -26.63

chart play

Report this Post Reply

Featured Broker Partners


Advertisement